Eli has 10 years of experience working in accounting and finance roles and currently is the Principal and Founder of Ninebark Group LLC, a consulting company assisting startups in the West Coast region of the US in matters of accounting and finance. Eli was previously an Accounting Manager at Juno Therapeutics, a publicly traded biopharmaceutical company with a pipeline of cancer immunotherapy drugs, now a part of Bristol-Myers Squibb. At Juno Eli helped successfully lead the establishment and maintenance of operational and financial accounting and compliance processes. Prior to Juno, Eli worked in the audit function at EY where he performed and led integrated financial audits of public and private clients in the technology, biotechnology, and manufacturing sectors.